|
 
Vaccines and Related Biological Products Advisory Committee (VRBPAC) May 22, 2025 Meeting Announcement on COVID-19 strain selection
Today, the FDA announced that on May 22, 2025, the FDA’s Vaccines and Related Biological Products Advisory Committee will meet in open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States.
About Us
The Public Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, patients and patient advocacy organizations, consumer groups, trade associations, think tanks and academia, and other interested parties, in order to better inform our policy making process, identify policy hurdles or misconceptions, and create strategic collaborations. For more information, please contact us at ForPatients@fda.hhs.gov. For patient specific inquiries, please contact us at Patients Ask FDA.
|
|
|
|
